Log in

Relevant bibliographies by topics / Carcinoma of Gall Bladder / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Carcinoma of Gall Bladder.

Dissertations / Theses on the topic 'Carcinoma of Gall Bladder'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Carcinoma of Gall Bladder.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Curtis-Barrett, Carmel Mary. "Gene transfer to the murine gall bladder." Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.624932.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Thrum, Stephan. "In vitro-Versuche mit dem Polo like-Kinase 1 Hemmstoff BI 2536 an Zelllinien von Gallenwegskarzinomen." Doctoral thesis, Universitätsbibliothek Leipzig, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-134869.

Full text

Abstract:

Karzinome der Gallenwege sind mit einer schlechten Prognose assoziiert. Eine potentiell kurative chirurgische Resektion ist bei der Mehrzahl der Patienten aufgrund des späten Zeitpunkts der Diagnosestellung nicht möglich, so dass derzeit vorrangig palliative Therapieansätze Anwendung finden. Das nur geringe Ansprechen auf konventionelle Radio- oder Zytostatikatherapie begründet die Notwendigkeit neuer Therapieansätze. Einen möglichen Angriffspunkt stellt hierbei die Polo-like-Kinase 1 (Plk1) dar, da ihre zentrale Rolle in der Regulation des Zellzyklus zunehmend erkannt und eine vermehrte Expre

APA, Harvard, Vancouver, ISO, and other styles

3

Rajab, Nor Fadilah. "Studies on human transitional cell bladder carcinoma." Thesis, University of Ulster, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.232852.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Moutsopoulos, Konstantinos. "Physically deformable models for simulation of laparoscopic surgery." Thesis, Imperial College London, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.339157.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Loskog, Angelica. "Immunogene Therapy of Bladder Carcinoma : A Preclinical Study." Doctoral thesis, Uppsala universitet, Enheten för onkologi, 2002. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2637.

Full text

Abstract:

This thesis comprises studies on murine and human models of bladder carcinoma with the aim to develop novel immunogene therapies. On the basis of the results presented in this thesis, a clinical trial is underway. The potential of activating the immune system to combat cancer has long intrigued immunologists. Research has now been intensified and clinically effective treatments are beginning to materialize. We evaluated the induction of anti-tumor responses by inserting immunomodulating genes into tumor cells with adenovectors. Human biopsies and cell lines were positive for adenovirus attachm

APA, Harvard, Vancouver, ISO, and other styles

6

McKnight, J. J. "Surrogate markers in transitional cell carcinoma of bladder." Thesis, Queen's University Belfast, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401757.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Маркевич, Ольга Василівна, Ольга Васильевна Маркевич, Olha Vasylivna Markevych, Е. А. Лазебник, Л. И. Величко та Л. Е. Карпенко. "Применение "Холивера" при заболеваниях желчевыводящей системы у детей". Thesis, Изд-во СумГУ, 2006. http://essuir.sumdu.edu.ua/handle/123456789/6977.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sjöström, Anna. "Radionuclide targeting with particular empahsis on urinary bladder carcinoma." Doctoral thesis, Uppsala University, Department of Oncology, Radiology and Clinical Immunology, 2001. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1097.

Full text

Abstract:

<p>The incidence of urinary bladder carcinoma is increasing and many patients die every year of this disease despite assumed radical therapy. Thus, there is a need for improved methods of diagnosis and therapy. Radionuclide targeting is based on achieving specific delivery of radioactive nuclides to tumour cells with minimal damage to surrounding normal tissues. Two possible target structures are the epidermal growth factor (EGF) receptor and the related receptor HER-2.</p><p>Cellular binding and retention of <sup>125</sup>I-EGF-dextran conjugates was investigated in two bladder carcinoma cell

APA, Harvard, Vancouver, ISO, and other styles

9

Sjöström, Anna. "Radionuclide targeting with particular empahsis on urinary bladder carcinoma /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2001. http://publications.uu.se/theses/91-554-5035-0/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Opiyo, Monica Naomi. "The role of glucocorticoid metabolism in bile acid homeostasis." Thesis, University of Edinburgh, 2016. http://hdl.handle.net/1842/25673.

Full text

Abstract:

Alterations in glucocorticoid (GC) biosynthesis and metabolism are associated with a variety of pathophysiological disorders including cholestasis, diabetes and other metabolic disorders. Bile acids (BA) are also important modulators of metabolic functions and regulate cholesterol, triglyceride and glucose homeostasis as well as being critical for dietary fat digestion, enterohepatic function, and postprandial thermogenesis. In intact cells and in vivo, the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme converts inactive GC precursors (cortisone in humans, and 11-dehydrocorticostero

APA, Harvard, Vancouver, ISO, and other styles

11

Luscombe, Michael John. "Differential display applied to transitional cell carcinoma of the bladder." Thesis, Imperial College London, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.394390.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Valentine, Andrea. "Prognostic factors in transitional cell carcinoma of the bladder (TCCB)." Thesis, University of Ulster, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.393767.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Price, Mandy Elizabeth. "Predictive testing of tumour radiosensitivity in transitional cell carcinoma of the bladder." Thesis, University of Ulster, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264819.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Olsson, Hans. "Stage T1 Urinary Bladder Carcinoma : Investigation of A Population-Based Cohort." Doctoral thesis, Linköpings universitet, Molekylär och immunologisk patologi, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-85017.

Full text

Abstract:

Approximately 2 300 new cases of urinary bladder carcinoma (UBC) are diagnosed every year in Sweden. This type of cancer is characterized as a long-standing disease with a high risk of recurrence and progression from an indolent to a more aggressive course. UBC occurs in a non-muscle-invasive form (stages Ta and T1), which is treated mainly with local resection and BCG instillation, and a muscle-invasive form (stage ≥ T2), for which the treatment of choice is irradiation or cystectomy. The aim of the research underlying this thesis was to explore the factors involved in tumor development and p

APA, Harvard, Vancouver, ISO, and other styles

15

Little, B. T. "Prospectic evaluation of markers for detection and progression for bladder carcinoma." Thesis, Queen's University Belfast, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403245.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Sami, Tariq A. "The molecular analysis of transitional cell carcinoma of the urinary bladder." Thesis, Queen's University Belfast, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.394618.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Goddard, Jonathan Charles. "Angiogenesis in superficial transitional cell carcinoma of the human urinary bladder." Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29477.

Full text

Abstract:

Aims: To determine whether microvessel density (MVD) could be measured in papillary superficial transitional cell carcinoma of the human urinary bladder in a simple, meaningful and reproducible way. Also, to determine whether angiogenesis, as measured by MVD, at presentation is related to subsequent recurrence or progression of superficial bladder cancer and its relationship to known angiogenic cytokines. Methods: Immunohistochemical techniques were used to measure MVD (using CD34), vascular endothelial growth factor (VEGF) thrombospondin-1 (TSP-1) (using both TSP Ab-4 and TSP Ab-7 antibodies)

APA, Harvard, Vancouver, ISO, and other styles

18

Saowarin, Meechusupaya Sudarat Manochiopinij. "Urinary enzymes and carcinoembryonic antigen in patients with carcinoma of the bladder /." Abstract, 1986. http://mulinet3.li.mahidol.ac.th/thesis/2529/29E-Saowarin-M.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

CAMPIONI, GLORIA. "Monolayers and three-dimensional cultures to investigate metabolic reprogramming in breast and bladder cancer." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2022. http://hdl.handle.net/10281/375413.

Full text

Abstract:

La riprogrammazione metabolica è stata osservata in molti tipi di cancro ed è considerata un tratto distintivi di questa malattia eterogenea multifattoriale. Comprendere i meccanismi che portano al riarrangiamento metabolico e come queste attività promuovono l’attivazione di proprietà maligne nel cancro può aiutare a sfruttare le alterazioni metaboliche a beneficio terapeutico. Nei tumori solidi le cellule tumorali interagiscono con il complesso habitat del microambiente tumorale (TME) che può modulare il metabolismo delle cellule tumorali e la loro sensibilità o resistenza al trattamento farm

APA, Harvard, Vancouver, ISO, and other styles

20

Jansson, Olof T. "On the role of nitric oxide in bladder cancer and renal cell carcinoma /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3405-3/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Saki, Zakaria Issa. "Studies of the response of muscle invasive bladder cancer to radiotherapy." Thesis, University of Plymouth, 2002. http://hdl.handle.net/10026.1/2837.

Full text

Abstract:

The purpose of this study was to investigate several biological markers that may predict the response of muscle invasive transitional cell carcinoma TCC of the bladder to radical radiotherapy. The specific markers chosen were tumour angiogenesis (CD31 &CD34), tumour cell proliferation (Ki-67) and apoptosis (bcl-2), intratumour macrophage infiltration (CD68) and p53. Archival formalin fixed paraffin embedded pre treatment bladder biopsies from 101 patients with muscle invasive TCC were obtained. All patients subsequently received radical radiotherapy as their only treatment for the disease. 4µm

APA, Harvard, Vancouver, ISO, and other styles

22

Gårdmark, Truls. "Urinary bladder carcinoma : studies of outcome of current management and experimental therapy /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6634.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Кравець, Олександр Валерійович, В. О. Братушка, Александр Валерьевич Кравец та Oleksandr Valeriiovych Kravets. "Досвід діагностики та лікування поліпів жовчного міхура". Thesis, Сумський державний університет, 2014. http://essuir.sumdu.edu.ua/handle/123456789/36441.

Full text

Abstract:

Нами проведено аналіз історій хвороби 32 хворих, оперованих з приводу поліпів (П) жовчного міхура (ЖМ). Середній вік – 45,1 ± 6,5 років. При цитуванні документа, використовуйте посилання http://essuir.sumdu.edu.ua/handle/123456789/36441

APA, Harvard, Vancouver, ISO, and other styles

24

Gårdmark, Truls. "Urinary Bladder Carcinoma – Studies of Outcome of Current Management and Experimental Therapy." Doctoral thesis, Uppsala University, Department of Surgical Sciences, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6634.

Full text

Abstract:

<p>The thesis concerns the epidemiology, current and possible future treatment of urothelial cancer of the urinary bladder. The Swedish National Quality Registry for Bladder Cancer 1997-2001 was used to explore epidemiology, current therapies and outcome. More common in men, the incidence for Ta and T1 tumours peaks in the age range 70-79 years. There were differences in treatment activity between the reporting regions. An increasing activity was seen. Older patients received less intravesical treatment, which was also a tendency for women. The five year relative survival for all stages (Ta-T4

APA, Harvard, Vancouver, ISO, and other styles

25

O'Kane, H. F. "The FAS death receptor pathway in transitional cell carcinoma of the bladder." Thesis, Queen's University Belfast, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426738.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Leckey, Joan Lesley. "Urinary and tumour markers of disease recurrence and prognosis in transitional cell carcinoma of the bladder." Thesis, University of Ulster, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.310119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Watson, Julie Karen. "The roles of the small leucine-rich repeat proteoglycans, osteomodulin and PRELP, in urothelial cell carcinoma." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608742.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Chiblen', S. V., I. Yu Olijnyk, and O. V. Tsyhykalo. "Features of the vascular bed anlage in the gall bladder and the cystic duct in human early prenatal ontogenesis." Thesis, БДМУ, 2017. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/16782.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Berrum, Svennung Ingela. "Carcinoma of the urinary bladder : aspects of treatment, costs and follow-up routines /." Göteborg : Göteborg University, Department of Urology, Institute of Clinical Sciences, The Sahlgrenska Academy at Göteborg University, Sahlgrenska University Hospital, 2007. http://hdl.handle.net/2077/7536.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Cartwright, Richard. "The complementation of the radiosensitive phenotype of a human bladder carcinoma cell line." Thesis, Institute of Cancer Research (University Of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294954.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Setyo, Laura Christina. "Immunohistochemical study of urothelial carcinoma of the urinary bladder: diagnostic and therapeutic implications." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/26760.

Full text

Abstract:

Invasive urothelial carcinoma (UC) is the most common form of urinary bladder cancer and most dogs ultimately die of the disease. It is derived from urothelium, a unique, highly specialised epithelium which lines the lower urinary tract and functions as a physical barrier as well as a sensory structure. Canine UC is believed to be an appropriate animal model because canine UC shares many characteristics with human UC. A substantive comparative study on tumorigenic molecules expressed by canine and human UC is anticipated as an important development toward understanding the mechanism. Tyrosin

APA, Harvard, Vancouver, ISO, and other styles

32

Hayes, Matthew Charles. "Fluorescence based assay for the identification of multidrug resistance in transitional cell bladder carcinoma." Thesis, University of Southampton, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.340505.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Nascimento, e. Pontes Merielen Garcia [UNESP]. "Ganhos e perdas genômicas em momentos sucessivos do carcinoma urotelial de bexiga humana." Universidade Estadual Paulista (UNESP), 2010. http://hdl.handle.net/11449/104572.

Full text

Abstract:

Made available in DSpace on 2014-06-11T19:33:24Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-08-27Bitstream added on 2014-06-13T20:05:14Z : No. of bitstreams: 1 nascimentoepontes_mg_dr_botfm.pdf: 553102 bytes, checksum: 6f4ebc00fc0583f012e1a99ab95ffefe (MD5)<br>Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)<br>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)<br>Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)<br>Toxicam<br>Urinary bladder carcinomas (UBC) frequently recur. During the intervals “free‐ofneoplasia”, between the ini

APA, Harvard, Vancouver, ISO, and other styles

34

Nascimento, e. Pontes Merielen Garcia. "Ganhos e perdas genômicas em momentos sucessivos do carcinoma urotelial de bexiga humana /." Botucatu, 2010. http://hdl.handle.net/11449/104572.

Full text

Abstract:

Orientador: João Lauro Viana de Camargo<br>Coorientador: Silvia Regina Rogatto<br>Banca: Claudia Aparecida Rainho<br>Banca: Mônica Vannucci Nunes Lipay<br>Banca: Carlos Márcio Nóbrega de Jesus<br>Banca: Leopoldo Alves Ribeiro Filho<br>Resumo: Não disponível<br>Abstract: Urinary bladder carcinomas (UBC) frequently recur. During the intervals "free‐ofneoplasia", between the initially diagnosed tumor and its recurrences, there are not undisputable histological alterations in the mucosa, although some studies have reported DNA damage in urothelial cells. In order to understand developmental charac

APA, Harvard, Vancouver, ISO, and other styles

35

Abbaoui, Besma. "BROCCOLI ISOTHIOCYANATES AS CHEMOPREVENTIVE AGENTS AND EPIGENETIC MODULATORS OF BLADDER CANCER." The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1312835540.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Adshead, James Michael. "The expression of class III PAX genes in transitional cell carcinoma of the human bladder." Thesis, Imperial College London, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Oehlschläger, Sven, Anka Baldauf, Diana Wiessner, Jörg Gellrich, Oliver W. Hakenberg, and Manfred P. Wirth. "Bladder Tumor Recurrence after Primary Surgery for Transitional Cell Carcinoma of the Upper Urinary Tract." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-133821.

Full text

Abstract:

Objective: Primary transitional cell carcinoma (TCC) of the upper urinary tract represents 6–8% of all TCC cases. Nephroureterectomy with removal of a bladder cuff is the treatment of choice. The rates of TCC recurrence in the bladder after primary upper urinary tract surgery described in the literature range between 12.5 and 37.5%. In a retrospective analysis we examined the occurrence of TCC after nephroureterectomy for upper tract TCC in patients without a previous history of bladder TCC at the time of surgery. Methods: Between 1990 and 2002, 29 patients underwent primary nephroureterectomy

APA, Harvard, Vancouver, ISO, and other styles

38

Oehlschläger, Sven, Anka Baldauf, Diana Wiessner, Jörg Gellrich, Oliver W. Hakenberg, and Manfred P. Wirth. "Bladder Tumor Recurrence after Primary Surgery for Transitional Cell Carcinoma of the Upper Urinary Tract." Karger, 2004. https://tud.qucosa.de/id/qucosa%3A27539.

Full text

Abstract:

Objective: Primary transitional cell carcinoma (TCC) of the upper urinary tract represents 6–8% of all TCC cases. Nephroureterectomy with removal of a bladder cuff is the treatment of choice. The rates of TCC recurrence in the bladder after primary upper urinary tract surgery described in the literature range between 12.5 and 37.5%. In a retrospective analysis we examined the occurrence of TCC after nephroureterectomy for upper tract TCC in patients without a previous history of bladder TCC at the time of surgery. Methods: Between 1990 and 2002, 29 patients underwent primary nephroureterectom

APA, Harvard, Vancouver, ISO, and other styles

39

Москаленко, Роман Андрійович, Роман Андреевич Москаленко, Roman Andriiovych Moskalenko та ін. "Морфологічний аналіз 3 випадків порцелянового жовчного міхура". Thesis, Сумський державний університет, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45117.

Full text

Abstract:

Порцеляновий жовчний міхур є рідкісним проявом хронічних захворювань жовчного міхура, характеризується кальцифікацією своєї стінки і зустрічається у 0,06-0,8% холецистектомій (Palermo M, 2011). За результатами різних досліджень, у 0-62% випадків пацієнти з ПЖМ виникає рак жовчного міхура (Stephen A.E, 2001, Cunningham S.C., 2007). Метою нашої роботи був морфологічний аналіз 3 клінічних випадків порцелянового жовчного міхура.

APA, Harvard, Vancouver, ISO, and other styles

40

Duffy, Peter Martin. "Intravesical chemotherapy for superficial bladder cancer : an in vitro study of anthracyclines, pH and multidrug resistance." Thesis, University of Southampton, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326586.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Matheus, Wagner Eduardo. "Carcinoma urotelial invasivo de bexiga primario versus progressivo : analise multicentrica de sobrevida global." [s.n.], 2007. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312203.

Full text

Abstract:

Orientadores: Ubirajara Ferreira, Fernandes Denardi<br>Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas<br>Made available in DSpace on 2018-08-09T15:47:05Z (GMT). No. of bitstreams: 1 Matheus_WagnerEduardo_D.pdf: 1544170 bytes, checksum: b8c2ff3d48db298c2b90e9243e4fad82 (MD5) Previous issue date: 2007<br>Resumo: O melhor tratamento para o carcinoma urotelial invasivo de bexiga é a cirurgia de cistectomia radical. O objetivo principal desse estudo foi de comparar a taxa de sobrevida global dos tumores músculo invasivos primários dos tumores invasivos progres

APA, Harvard, Vancouver, ISO, and other styles

42

Suh, Lara K. "Time Interval to Diagnosis of Bladder Cancer and Its Associated Outcomes." Yale University, 2008. http://ymtdl.med.yale.edu/theses/available/etd-08282007-145441/.

Full text

Abstract:

The purpose of this study is to investigate whether a prolonged delay in diagnosis of bladder cancer will result in worse outcomes for those patients, compared to those patients with a shorter diagnostic time interval. Data was collected on 247 patients newly diagnosed with transitional cell carcinoma of the bladder from January 1996 to December 2006 (10 years). The medical records of these patients were reviewed for demographics, pathological stage, date of consultation to the genitourinary (GU) service, and date of diagnosis by transurethral resection of bladder tumor (TURBT). The specialty

APA, Harvard, Vancouver, ISO, and other styles

43

Ninalga, Christina. "Cancer Immunotherapy : A Preclinical Study of Urinary Bladder Cancer." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6761.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Häggström, Christel. "Metabolic factors and risk of prostate, kidney, and bladder cancer." Doctoral thesis, Umeå universitet, Urologi och andrologi, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-83947.

Full text

Abstract:

Background: Prostate cancer is the most common cancer in Sweden with around 10,000 new cases every year. Kidney and bladder cancer are less common with 1,000 and 2,000 new cases annually, respectively. The incidence of these cancer sites is higher in developed, than in developing countries, suggesting an association between lifestyle and cancer risk. The aims of this thesis were to investigate body mass index (BMI), blood pressure, and blood levels of glucose, total cholesterol, and triglycerides as risk factors for prostate, kidney, and bladder cancer. Furthermore, we aimed at assess probabil

APA, Harvard, Vancouver, ISO, and other styles

45

Rouanne, Mathieu. "Mechanisms of Resistance to BCG Immunotherapy in Bladder Cancer." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS342.

Full text

Abstract:

Le cancer de la vessie est le 9ème cancer le plus fréquent avec 435 000 nouveaux cas diagnostiqués chaque année et 165 000 décès par an dans le monde. Au diagnostic, 70-80% des cancers de la vessie sont tumeurs superficielles n’infiltrant pas le muscle vésical (TVNIM). Depuis près de 40 ans, les instillations intra-vésicales de bacille de Calmette-Guérin (BCG) sont le traitement de référence des TVNIM ayant un risque élevé de progression (T1, carcinome in situ, Ta haut grade). Malgré un traitement bien conduit, le taux de récidive est d'environ 50%, et la progression vers une tumeur infiltrant

APA, Harvard, Vancouver, ISO, and other styles

46

Abou, Farha Khalid Mohamed Mohamed. "Diagnostic and prognostic value of laminin as a biochemical and a histological marker in human bladder carcinoma." Maastricht : Maastricht : Universitaire Pers Maastricht ; University Library, Maastricht University [Host], 1992. http://arno.unimaas.nl/show.cgi?fid=6506.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Júnior, Nelson Gaspar Dip. "Análise de expressão de micro RNA em carcinoma urotelial de bexiga." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/5/5153/tde-10102012-100047/.

Full text

Abstract:

Introdução: O câncer de bexiga é a segunda neoplasia maligna mais frequente do trato urinário, com 386.000 casos estimados e 150.000 mortes para 2011 no mundo. Noventa e cinco por cento são carcinomas uroteliais (CUB) papilíferos não músculo-invasivos de baixo grau, que apresentam altas taxas de recidiva, mas raramente progridem. Tumores invasivos de alto grau representam 10-20% dos diagnósticos, são altamente agressivos levando à mortalidade elevada. O conhecimento das vias moleculares envolvidas na carcinogênese dessa neoplasia é importante para a identificação de novos marcadores para diagn

APA, Harvard, Vancouver, ISO, and other styles

48

Pereira, Carla Sofia Domingues. "Via de sinalização mTOR no carcinoma urotelial da bexiga." Master's thesis, [s.n.], 2014. http://hdl.handle.net/10284/4673.

Full text

Abstract:

Trabalho de Projeto apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Análises Laboratoriais Especializadas, área de especialização em Análise Biomédica<br>Mundialmente, o cancro da bexiga (CB) é o 7º tipo de cancro mais frequente em homens e o 17 º mais frequente em mulheres. É uma doença com etiologia multifatorial associada a vários agentes ambientais e genéticos, dos quais o tabagismo é o fator de risco mais importante. Os carcinomas uroteliais da bexiga (CUBs) são geralmente superficiais em 70% a 80% dos pacientes e invasores em 20% a

APA, Harvard, Vancouver, ISO, and other styles

49

Vasala, K. (Kaija). "Matrix metalloproteinase MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in bladder carcinoma." Doctoral thesis, University of Oulu, 2008. http://urn.fi/urn:isbn:9789514288746.

Full text

Abstract:

Abstract Bladder cancer when superficial has a good prognosis but it has a high recurrence risk and about 10–15% of the superficial carcinomas will progress into muscle invasive or metastatic type. The most powerful factor for predicting the behavior of bladder carcinoma is the stage of the tumor. Invasion to the lamina propria increases the risk of recurrence and progress to muscle-invasive tumor. Also grade of the tumor and tumor multiplicity associates with high risk for recurrence. New markers are still needed to find those patients who need more and better treatments to avoid the recurren

APA, Harvard, Vancouver, ISO, and other styles

50

Gray, S. B. "The role of antisense G3139 in a novel 'in vivo' model of transitional cell carcinoma of the bladder." Thesis, Queen's University Belfast, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403239.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!